CEO’s New Option Vesting Signals Strategic Shift Amid Mixed Insider Trading at Passage Bio
Passage Bio insider activity signals a strategic shift: CEO’s new stock option vesting and mixed buying/selling suggest a focus on long‑term growth amid a 26% decline.
3 minutes to read